ArticleBMC nutrition2026
Association between nutritional deficiency anemia and clinical outcomes in patients with heart failure: a multi-institutional population-based Study.
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveNutritional deficiencies have been increasingly recognized as potential contributors to adverse cardiovascular outcomes. However, their relationship with clinical outcomes in patients with heart failure (HF) remains unclear. This study aimed to evaluate the association between nutritional deficiency anemia (NDA) and clinical outcomes in patients with HF.
methodsWe conducted a retrospective cohort study, identifying 1,558,577 adult patients diagnosed with HF. Among these, 86,186 patients were classified as having NDA. A 1:1 propensity score matching (PSM) was performed, resulting in 86,181 matched pairs. The primary outcome was a composite of all-cause mortality, HF exacerbation (HFE), and major adverse cardiovascular events (MACE). Secondary outcomes included individual components of the composite outcome. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models.
resultsThe composite outcome occurred more frequently in the NDA group than in the control group (HR: 1.414, 95% CI: 1.38–1.449, p < 0.0001). Secondary outcomes further demonstrated an increased risk of all-cause mortality (HR: 1.484, 95% CI: 1.432–1.539), HFE (HR: 1.440, 95% CI: 1.396–1.486), and MACE (HR: 1.278, 95% CI: 1.22–1.338), all with p < 0.0001.
conclusionNDA was associated with worse clinical outcomes in patients with HF, including increased risks of all-cause mortality, HFE, and MACE. These findings suggest that coded nutritional deficiency anemia may represent a clinically relevant prognostic marker in HF populations. Further studies are warranted to clarify the underlying mechanisms and clinical implications of this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.